InnovAge Holding Corp. (OTCMKTS:INNV – Get Rating) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $6.61 and traded as high as $6.92. InnovAge shares last traded at $6.84, with a volume of 21,591 shares changing hands.
Analyst Ratings Changes
INNV has been the topic of several analyst reports. JPMorgan Chase & Co. upped their price objective on InnovAge from $5.00 to $8.00 and gave the company a “neutral” rating in a research note on Wednesday, February 8th. Citigroup cut their price target on InnovAge from $8.00 to $7.00 in a research note on Friday, May 12th. Finally, The Goldman Sachs Group increased their price target on InnovAge from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Wednesday, February 15th.
InnovAge Stock Performance
The company has a fifty day moving average of $6.61 and a two-hundred day moving average of $7.02. The company has a market cap of $927.71 million, a price-to-earnings ratio of -22.06 and a beta of -0.01. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.57 and a current ratio of 1.57.
Institutional Investors Weigh In On InnovAge
Several hedge funds and other institutional investors have recently modified their holdings of the company. Captrust Financial Advisors grew its holdings in InnovAge by 4,122.1% during the first quarter. Captrust Financial Advisors now owns 5,742 shares of the company’s stock worth $37,000 after buying an additional 5,606 shares in the last quarter. Barclays PLC lifted its position in shares of InnovAge by 533.4% during the 4th quarter. Barclays PLC now owns 5,137 shares of the company’s stock valued at $37,000 after buying an additional 4,326 shares during the last quarter. UBS Group AG lifted its position in shares of InnovAge by 99.6% during the 4th quarter. UBS Group AG now owns 9,982 shares of the company’s stock valued at $72,000 after buying an additional 4,982 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of InnovAge during the 3rd quarter valued at $72,000. Finally, MetLife Investment Management LLC bought a new stake in shares of InnovAge during the 4th quarter valued at $83,000. Institutional investors own 12.44% of the company’s stock.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
- Get a free copy of the StockNews.com research report on InnovAge (INNV)
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
- Foot Locker And The Ebbing Tide Of Discretionary Spending
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.